| Consensus and future directions on the definition of high on-treatment platelet reactivity to adenosine diphosphate L Bonello, US Tantry, R Marcucci, R Blindt, DJ Angiolillo, R Becker, ... Journal of the American College of Cardiology 56 (12), 919-933, 2010 | 1395 | 2010 |
| Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia and bleeding US Tantry, L Bonello, D Aradi, MJ Price, YH Jeong, DJ Angiolillo, ... Journal of the American College of Cardiology 62 (24), 2261-2273, 2013 | 921 | 2013 |
| Impact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosis P Buonamici, R Marcucci, A Migliorini, GF Gensini, A Santini, R Paniccia, ... Journal of the American College of Cardiology 49 (24), 2312-2317, 2007 | 886 | 2007 |
| Cardiovascular death and nonfatal myocardial infarction in acute coronary syndrome patients receiving coronary stenting are predicted by residual platelet reactivity to ADP … R Marcucci, AM Gori, R Paniccia, B Giusti, S Valente, C Giglioli, ... Circulation 119 (2), 237-242, 2009 | 677 | 2009 |
| High residual platelet reactivity after clopidogrel loading and long-term cardiovascular events among patients with acute coronary syndromes undergoing PCI G Parodi, R Marcucci, R Valenti, AM Gori, A Migliorini, B Giusti, ... Jama 306 (11), 1215-1223, 2011 | 503 | 2011 |
| Impact of platelet reactivity on clinical outcomes after percutaneous coronary intervention: a collaborative meta-analysis of individual participant data SS Brar, J Ten Berg, R Marcucci, MJ Price, M Valgimigli, HS Kim, G Patti, ... Journal of the American College of Cardiology 58 (19), 1945-1954, 2011 | 500 | 2011 |
| Comparison of prasugrel and ticagrelor loading doses in ST-segment elevation myocardial infarction patients: RAPID (Rapid Activity of Platelet Inhibitor Drugs) primary PCI study G Parodi, R Valenti, B Bellandi, A Migliorini, R Marcucci, V Comito, ... Journal of the American College of Cardiology 61 (15), 1601-1606, 2013 | 496 | 2013 |
| COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET) M Marietta, W Ageno, A Artoni, E De Candia, P Gresele, M Marchetti, ... Blood Transfusion 18 (3), 167, 2020 | 438 | 2020 |
| Bleeding and stent thrombosis on P2Y12-inhibitors: collaborative analysis on the role of platelet reactivity for risk stratification after percutaneous coronary … D Aradi, A Kirtane, L Bonello, PA Gurbel, US Tantry, K Huber, ... European heart journal 36 (27), 1762-1771, 2015 | 398 | 2015 |
| Relation of cytochrome P450 2C19 loss-of-function polymorphism to occurrence of drug-eluting coronary stent thrombosis B Giusti, AM Gori, R Marcucci, C Saracini, I Sestini, R Paniccia, ... The American journal of cardiology 103 (6), 806-811, 2009 | 321 | 2009 |
| Incidence and clinical impact of dual nonresponsiveness to aspirin and clopidogrel in patients with drug-eluting stents AM Gori, R Marcucci, A Migliorini, R Valenti, G Moschi, R Paniccia, ... Journal of the American College of Cardiology 52 (9), 734-739, 2008 | 311 | 2008 |
| Cytochrome P450 2C19 loss-of-function polymorphism, but not CYP3A4 IVS10+ 12G/A and P2Y12 T744C polymorphisms, is associated with response variability to dual antiplatelet … B Giusti, AM Gori, R Marcucci, C Saracini, I Sestini, R Paniccia, S Valente, ... Pharmacogenetics and genomics 17 (12), 1057-1064, 2007 | 303 | 2007 |
| Clopidogrel non-responsiveness and risk of cardiovascular morbidity F Sofi, R Marcucci, AM Gori, B Giusti, R Abbate, GF Gensini Thrombosis and haemostasis 103 (04), 00-00, 2010 | 288 | 2010 |
| Homocysteine and Coronary Heart Disease: Meta-analysis of MTHFR Case-Control Studies, Avoiding Publication Bias R Clarke, DA Bennett, S Parish, P Verhoef, M Dötsch-Klerk, M Lathrop, ... PLoS medicine 9 (2), e1001177, 2012 | 278 | 2012 |
| Working Group on On-Treatment Platelet Reactivity. Consensus and update on the definition of on-treatment platelet reactivity to adenosine diphosphate associated with ischemia … US Tantry, L Bonello, D Aradi, MJ Price, YH Jeong, DJ Angiolillo, ... J Am Coll Cardiol 62 (24), 2261-2273, 2013 | 267 | 2013 |
| Cytochrome P450 2C19* 2 polymorphism and cardiovascular recurrences in patients taking clopidogrel: a meta-analysis F Sofi, B Giusti, R Marcucci, AM Gori, R Abbate, GF Gensini The pharmacogenomics journal 11 (3), 199-206, 2011 | 240 | 2011 |
| Different methodologies for evaluating the effect of clopidogrel on platelet function in high‐risk coronary artery disease patients R Paniccia, E Antonucci, AM Gori, R Marcucci, C Giglioli, D Antoniucci, ... Journal of Thrombosis and Haemostasis 5 (9), 1839-1847, 2007 | 227 | 2007 |
| Relationship between high platelet turnover and platelet function in high-risk patients with coronary artery disease on dual antiplatelet therapy F Cesari, R Marcucci, R Caporale, R Paniccia, E Romano, GF Gensini, ... Thrombosis and haemostasis 99 (11), 930-935, 2008 | 213 | 2008 |
| Ticagrelor crushed tablets administration in STEMI patients: the MOJITO study G Parodi, I Xanthopoulou, B Bellandi, V Gkizas, R Valenti, S Karanikas, ... Journal of the American College of Cardiology 65 (5), 511-512, 2015 | 206 | 2015 |
| Ticagrelor in patients with diabetes and stable coronary artery disease with a history of previous percutaneous coronary intervention (THEMIS-PCI): a phase 3, placebo … DL Bhatt, PG Steg, SR Mehta, LA Leiter, T Simon, K Fox, C Held, ... The Lancet 394 (10204), 1169-1180, 2019 | 201 | 2019 |
